GlassScriptPhysician profile
Elizabeth Raynor
NPI 1548638695
$1,433.82
in general payments reported to CMS, 2019-2025
15 companies · $847 in 2025
The $847 reported for 2025 was more than what 84% of Primary Care providers received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $92.05 · 2022: $28.19 · 2023: $57.07 · 2024: $409 · 2025: $847.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,304 · Education: $9.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,303.93 |
| Education | $9.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $278.12 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $256.87 | 2022-2025 | Mounjaro, Zepbound, Trulicity |
| Astrazeneca Pharmaceuticals LP | $228.39 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Abbvie INC. | $195.17 | 2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $70.44 | 2024-2025 | Caplyta |
| Glaxosmithkline, LLC. | $63.21 | 2021-2025 | Trelegy Ellipta, Bexsero, Arexvy |
| Abbott Laboratories | $62.81 | 2023-2025 | Eterna |
| Xeris Pharmaceuticals, INC. | $52.08 | 2021-2025 | Gvoke Hypopen |
| Saluda Medical Americas, INC. | $47.14 | 2024 | Evoke |
| Vanda Pharmaceuticals INC. | $42.69 | 2025 | Hetlioz, Fanapt |
| Pfizer INC. | $38.09 | 2025 | |
| Exact Sciences Corporation | $33.35 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Lundbeck LLC | $24.16 | 2025 | Rexulti |
| Novartis Pharmaceuticals Corporation | $23.22 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.08 | 2024 | Tradjenta, Synjardy, Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Raynor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.